The CPI(M) has urged the Indian government to issue a compulsory license for Remdesivir to facilitate generic manufacturing. Additionally, the EPO has developed new patent search strategies for COVID-19, and an upcoming EUIPO-EPO conference will address intellectual property issues in additive manufacturing.
Read more about CPI(M) asks Government to issue compulsory license for Remdesivir, EPO creates search strategies to help fight against COVID-19 and more patent newsTag: Remdesivir
Facebook signs Licensing Deal with Saregama, Amazon and Slack sign Licensing Deal, OTT Release of Films irks Multiplex Owners and more
The post reviews major licensing developments in India, including Saregama’s deals with Facebook and Spotify, Amazon’s collaboration with Slack, and the contentious shift of film releases to OTT platforms. It also covers the licensing arrangement between Gilead and Cipla for Remdesivir production.
Read more about Facebook signs Licensing Deal with Saregama, Amazon and Slack sign Licensing Deal, OTT Release of Films irks Multiplex Owners and more